Hydroxyethyl Starch 130/0.4 and the Risk of Acute Kidney Injury After Cardiopulmonary Bypass: A Single-Center Retrospective Study.

Journal: Journal of cardiothoracic and vascular anesthesia

PMID: 26774199

Abstract

OBJECTIVES: To investigate whether using hydroxyethyl starch (HES) 130/0.4 as a pump prime and for intraoperative fluid therapy is associated with postoperative acute kidney injury (AKI) after adult cardiac surgery.

Authors

Marc-Gilbert Lagny

Departments of Clinical Perfusion.
Laurence Roediger

Anesthesia and Intensive Care Medicine.
Jean-Noel Koch

Departments of Clinical Perfusion.
Fanny Dubois

Pharmacy, Liege, Belgium.
Marc Senard

Anesthesia and Intensive Care Medicine.
Anne-Françoise Donneau

Public Health, CHU of Liege, Liege, Belgium.
Marie Bernard Hubert

Anesthesia and Intensive Care Medicine.
Gregory A Hans

Anesthesia and Intensive Care Medicine. Electronic address: G.Hans@chu.ulg.ac.be.

Keywords

Acute Kidney Injury Aged Aged, 80 and over Cardiopulmonary Bypass Crystalloid Solutions Female Fluid Therapy Humans Hydroxyethyl Starch Derivatives Intraoperative Care Isotonic Solutions Male Middle Aged Postoperative Complications Postoperative Period Retrospective Studies Severity of Illness Index

External Resources

View on PubMed Access via DOI PubMed (26774199)

Hydroxyethyl Starch 130/0.4 and the Risk of Acute Kidney Injury After Cardiopulmonary Bypass: A Single-Center Retrospective Study.

Abstract

Authors

Keywords

External Resources

Popular Topics

Recent Journals